Global Health (NSE:MEDANTA) YoY EBITDA Growth : 7.89% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Global Health YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Global Health's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 7.89%.

Global Health's EBITDA per Share for the three months ended in Mar. 2024 was ₹7.69.

Global Health YoY EBITDA Growth Historical Data

The historical data trend for Global Health's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Health YoY EBITDA Growth Chart

Global Health Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

-3.29

118.47

35.19

24.64

Global Health Quarterly Data
	Mar20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial								96.12	32.99	27.43	32.59	7.89

Global Health YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Global Health's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(32.533	-	26.102)	/	\| 26.102 \|
=	24.64 %

Global Health's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(7.685	-	7.123)	/	\| 7.123 \|
=	7.89 %

Global Health YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Global Health's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Health (NSE:MEDANTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Health Ltd (NSE:MEDANTA) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

543654:India

Address

E - 18, Medanta - The Medicity, Defence Colony, New Delhi, IND, 110024

Website

https://www.medanta.org

Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.

Global Health (NSE:MEDANTA) Headlines

No Headlines